Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Consolidative Prostate Radiotherapy in Metastatic Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating consolidative radiotherapy for metastatic prostate cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Elective Adaptive Radiation With SBRT for Improved DurabilitY of Response [NA]
A clinical trial evaluating elective adaptive radiation with SBRT to improve durability of response in prostate cancer with nodal involvemen…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer [NA]
This clinical trial update describes the use of multiparametric MRI to evaluate cancer stage and inform treatment planning in patients with …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer [Phase 2, Phase 3]
This clinical trial update describes a Phase 2/3 study comparing whole-gland boost radiotherapy strategies versus SBRT monotherapy for PSMA-…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Comparing the Reliability of Expressed Prostatic Secretion (EPS) and Post Massage Urine (PMU) for the Prediction of Prostate Cancer Biopsy Outcome [NA]
This clinical trial compares expressed prostatic secretion and post-massage urine as predictors of biopsy outcomes for prostate cancer; the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: 177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer [Phase 1]
A Phase 1 clinical trial update announcing recruitment for Lutetium-177 PSMA-617 in combination with liver-directed therapy for metastatic c…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Cardiac MRI in Measuring the Impact of Anti-androgen Treatment on Cardiac Function in Patients With Prostate Cancer [NA]
A clinical trial registry entry from Ohio State University describes using cardiac MRI to measure how anti-androgen therapy affects cardiac …
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer [EARLY_Phase 1]
This clinical trial update describes a Phase 1 study from the University of Wisconsin, Madison, evaluating imaging and genomic biomarkers to…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Hispanic Adapted and Culturally Relevant Exercising Together [NA]
Trial update describes a Hispanic-adapted, culturally relevant exercise program for cancer patients and survivors, including prostate cancer…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Radiomics of Treatment-naive Prostate Cancer Patients on Multiparametric MRI for Risk Stratification and Treatment Outcomes Predictions [NA]
This clinical trial entry describes radiomics research using treatment-naive prostate cancer patients undergoing multiparametric MRI to supp…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: 18F-PSMA PET/CT Versus CT Alone in Assessment of Prostatic Cancer Patients
A clinical trial compares 18F-PSMA PET/CT versus CT alone for assessing prostate cancer and is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec [Phase 2]
Clinical trial update describes a Phase 2 biomarker study of Aglatimagene Besadenovec in men with localized prostate cancer treated with rad…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating treatment of high-risk prostate cancer guided by novel diagnostic radio- and molecular tracers is curr…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer [Phase 2]
A Phase 2 clinical trial is evaluating neoadjuvant ADT plus darolutamide with pembrolizumab, followed by adjuvant pembrolizumab, in molecula…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Faecal Incontinence in Prostate Cancer Survivors Treated Whith Radiotherapy
Clinical trial update noting that the study on fecal incontinence in prostate cancer survivors treated with radiotherapy is currently active…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer
This clinical trial update covers validation of a platelet proteomic assay for diagnosing and monitoring prostate cancer; the study is spons…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: PSMA-PET: Deep Radiomic Biomarkers of Progression and Response Prediction in Prostate Cancer [Phase 3]
A Phase 3 clinical trial is investigating PSMA-PET radiomic biomarkers to predict progression and treatment response in prostate cancer, and…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Stem Cells for Erectile Dysfunction Post RALP [Phase 1, Phase 2]
A stem cell therapy trial for erectile dysfunction after radical prostatectomy is in Phase 1/2 and not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: The Use of Artificial Intelligence Generated Contours in Radiation Planning of the Prostate Brachytherapy [NA]
This clinical trial update describes using artificial intelligence-generated contours to aid radiation planning in prostate brachytherapy, s…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Phase III Adaptive Adaptive Stereostactic Body Radiotherapy (SBRT) With Dose Escalation for High-Risk Prostate Cancer [NA]
An update on a Phase III adaptive SBRT trial with dose escalation for high-risk prostate cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery. [NA]
A non-inferiority clinical trial compares salvage pelvic radiotherapy given in 25 fractions (62.5 Gy) versus 20 fractions (52.5 Gy) for recu…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer [NA]
This clinical trial update evaluates focal high-dose-rate brachytherapy as a treatment for prostate cancer. The study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: These Studies Assess Surgeons' Physical and Ergonomic Workloads. Study 1 Compares Laparoscopic vs. Hugo RAS Robotic Approaches for Rectal Resection. Study 2 Compares Hugo RAS vs. Da Vinci Xi for Prostatectomy. Both Track Physiological Stress, Surgical Strain Phases, and Exerted Force. [NA]
A clinical trial update describing two comparative studies on surgical approaches—laparoscopic versus Hugo RAS robotic for rectal resection …
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Mechanisms of Resistance to PSMA Radioligand Therapy
A UCSF-sponsored clinical trial is studying mechanisms of resistance to PSMA radioligand therapy in prostate cancer. The work aims to unders…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Prostate Stereotactic Radiation and Radio-induced Lymphocyte Apoptosis for Predicting Late Toxicities in Prostate Cancer (PROSTERA) [NA]
This clinical trial (PROSTERA) studies whether stereotactic radiation and radio-induced lymphocyte apoptosis can predict late toxicities in …